{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:48:01Z","timestamp":1763642881739,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":96,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811534485"},{"type":"electronic","value":"9789811534492"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-981-15-3449-2_13","type":"book-chapter","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T16:06:24Z","timestamp":1590163584000},"page":"375-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Epigenetic Regulation of Scleroderma and Its Clinical Application"],"prefix":"10.1007","author":[{"given":"Yangyang","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,23]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0111266","volume":"9","author":"G Alsaleh","year":"2014","unstructured":"Alsaleh G, Francois A, Philippe L, Gong YZ, Bahram S, Cetin S, Pfeffer S, Gottenberg JE, Wachsmann D, Georgel P, Sibilia J (2014) MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts. PLoS ONE 9:10","journal-title":"PLoS ONE"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/BOR.0000000000000112","volume":"26","author":"N Altorok","year":"2014","unstructured":"Altorok N, Wang Y, Kahaleh B (2014) Endothelial dysfunction in systemic sclerosis. Curr Opin Rheumatol 26:6","journal-title":"Curr Opin Rheumatol"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/annrheumdis-2014-205303","volume":"74","author":"N Altorok","year":"2015","unstructured":"Altorok N, Tsou PS, Coit P, Khanna D, Sawalha AH (2015) Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Ann Rheum Dis 74:8","journal-title":"Ann Rheum Dis"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","volume":"44","author":"FC Arnett","year":"2001","unstructured":"Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD (2001) Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheumatol 44:6","journal-title":"Arthritis Rheumatol"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1331-z","volume":"19","author":"CM Artlett","year":"2017","unstructured":"Artlett CM, Sassi-Gaha S, Hope JL, Feghali-Bostwick CA, Katsikis PD (2017) Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis. Arthritis Res Therapy 19:1","journal-title":"Arthritis Res Therapy"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.biocel.2015.06.004","volume":"67","author":"Yoshihide Asano","year":"2015","unstructured":"Asano Y (2015) Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis. Int J Biochem Cell Biol 67:86\u201391","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2010.06.008","volume":"59","author":"Y Asano","year":"2010","unstructured":"Asano Y, Bujor AM, Trojanowska M (2010) The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. J Dermatol Sci 59:3","journal-title":"J Dermatol Sci"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.humimm.2018.01.003","volume":"79","author":"S Aslani","year":"2018","unstructured":"Aslani S, Sobhani S, Gharibdoost F, Jamshidi A, Mahmoudi M (2018) Epigenetics and pathogenesis of systemic sclerosis; the ins and outs. Hum Immunol 79:3","journal-title":"Hum Immunol"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00403-013-1410-1","volume":"305","author":"O Babalola","year":"2013","unstructured":"Babalola O, Mamalis A, Lev-Tov H, Jagdeo J (2013) The role of microRNAs in skin fibrosis. Arch Dermatol Res 305:9","journal-title":"Arch Dermatol Res"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:2","journal-title":"Cell"},{"key":"13_CR11","first-page":"7","volume":"140","author":"C Bergmann","year":"2015","unstructured":"Bergmann C, Distler JH (2015) Systemic sclerosis\u2014an update. Dtsch Med Wochenschr 140:7","journal-title":"Dtsch Med Wochenschr"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1586\/1744666X.2013.848792","volume":"9","author":"FV Castelino","year":"2013","unstructured":"Castelino FV, Varga J (2013) Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development. Expert Rev Clin Immunol. 9:11","journal-title":"Expert Rev Clin Immunol."},{"key":"13_CR13","doi-asserted-by":"crossref","unstructured":"Chen S, Pu W, Guo S, Jin L, He D, Wang J (2019) Genome-wide DNA methylation profiles reveal common epigenetic patterns of interferon-related genes in multiple autoimmune diseases. Front Genet 10:223","DOI":"10.3389\/fgene.2019.00223"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1371\/journal.pone.0115596","volume":"9","author":"M Ciechomska","year":"2014","unstructured":"Ciechomska M, O\u2019Reilly S, Suwara M, Bogunia-Kubik K, van Laar JM (2014) MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-beta activated kinase 1 binding protein 1, implications for systemic sclerosis. PLoS One 9:12","journal-title":"PLoS One"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/eci.12776","volume":"47","author":"M Ciechomska","year":"2017","unstructured":"Ciechomska M, Zarecki P, Merdas M, Swierkot J, Morgiel E, Wiland P, Maslinski W, Bogunia-Kubik K (2017) The role of microRNA-5196 in the pathogenesis of systemic sclerosis. Eur J Clin Invest 47:8","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"13_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"Annemieke J.M. de RUIJTER","year":"2003","unstructured":"de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370(Pt 3):737\u2013749","journal-title":"Biochemical Journal"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2012-203194","volume":"73","author":"C Dees","year":"2014","unstructured":"Dees C, Schlottmann I, Funke R, Distler A, Palumbo-Zerr K, Zerr P, Lin NY, Beyer C, Distler O, Schett G, Distler JH (2014) The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Ann Rheum Dis 73:6","journal-title":"Ann Rheum Dis"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.autrev.2016.01.007","volume":"15","author":"AC Desbois","year":"2016","unstructured":"Desbois AC, Cacoub P (2016) Systemic sclerosis: an update in 2016. Autoimmun Rev 15:5","journal-title":"Autoimmun Rev"},{"issue":"5","key":"13_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jid.2017.12.003","volume":"138","author":"Weifeng Ding","year":"2018","unstructured":"Ding W, Pu W, Wang L, Jiang S, Zhou X, Tu W, Yu L, Zhang J, Guo S, Liu Q, Ma Y, Chen S, Wu W, Reveille J, Zou H, Jin L, Wang J (2017) Genome-wide DNA methylation analysis in systemic sclerosis reveals hypomethylation of IFN-associated genes in CD4(+) and CD8(+) T Cells. J Investig Derm 138(5):1069\u20131077","journal-title":"Journal of Investigative Dermatology"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00018-009-0045-z","volume":"66","author":"JT Dong","year":"2009","unstructured":"Dong JT, Chen C (2009) Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci 66:16","journal-title":"Cell Mol Life Sci"},{"key":"13_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbrc.2009.04.023","volume":"383","author":"S Fan","year":"2009","unstructured":"Fan S, Zhang X (2009) CpG island methylation pattern in different human tissues and its correlation with gene expression. Biochem Biophys Res Commun 383:4","journal-title":"Biochem Biophys Res Commun"},{"key":"13_CR22","unstructured":"Feghali-Bostwick C, Medsger Jr TA, Wright TM (2013) Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheumatol 48:7"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/jid.2012.453","volume":"133","author":"AK Ghosh","year":"2013","unstructured":"Ghosh AK, Bhattacharyya S, Lafyatis R, Farina G, Yu J, Thimmapaya B, Wei J, Varga J (2013) p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-\u03b2: epigenetic feed-forward amplification of fibrosis. J Investig Dermatology 133:5","journal-title":"J Investig Dermatology"},{"issue":"6","key":"13_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/art.40437","volume":"70","author":"Justin Gillespie","year":"2018","unstructured":"Gillespie J, Ross RL, Corinaldesi C, Esteves F, Derrett-Smith E, McDermott MF, Doody GM, Denton CP, Emery P, Del GF (2018) TGF\u03b2 activation primes canonical Wnt signaling through the downregulation of AXIN2. Arthritis Rheumatol 70:6","journal-title":"Arthritis & Rheumatology"},{"issue":"1","key":"13_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clim.2010.06.004","volume":"137","author":"Antonello Giovannetti","year":"2010","unstructured":"Giovannetti A, Rosato E, Renzi C, Maselli A, Gambardella L, Giammarioli AM, Palange P, Paoletti P, Pisarri S, Salsano F, Malorni Wand, Pierdominici M (2010) Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. Clin Immunol 137:1","journal-title":"Clinical Immunology"},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/exd.12767","volume":"24","author":"M Hattori","year":"2015","unstructured":"Hattori M, Yokoyama Y, Hattori T, Motegi S, Amano H, Hatada I, Ishikawa O (2015) Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts. Exp Dermatol 24:11","journal-title":"Exp Dermatol"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4049\/jimmunol.1100876","volume":"188","author":"N Honda","year":"2012","unstructured":"Honda N, Jinnin M, Kajihara I, Makino T, Makino K, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) TGF-beta-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. J Immunol 188:7","journal-title":"J Immunol"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajpath.2012.09.023","volume":"182","author":"N Honda","year":"2013","unstructured":"Honda N, Jinnin M, Kira-Etoh T, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2013) miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin beta3. Am J Pathol 182:1","journal-title":"Am J Pathol"},{"key":"13_CR29","first-page":"8","volume":"56","author":"LC Huber","year":"2007","unstructured":"Huber LC, Distler JH, Moritz F, Hemmatazad H, Hauser T, Michel BA, Gay RE, Matucci-Cerinic M, Gay S, Distler O, Jungel A (2007) Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum 56:8","journal-title":"Arthritis Rheum"},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/art.39312","volume":"67","author":"Y Ichimura","year":"2015","unstructured":"Ichimura Y, Asano Y, Akamata K, Noda S, Taniguchi T, Takahashi T, Toyama T, Tada Y, Sugaya M, Sato S, Kadono T (2015) Progranulin overproduction due to Fli-1 deficiency contributes to the resistance of dermal fibroblasts to tumor necrosis factor in systemic sclerosis. Arthritis Rheumatol 67:12","journal-title":"Arthritis Rheumatol"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00403-013-1431-9","volume":"306","author":"Y Ichimura","year":"2014","unstructured":"Ichimura Y, Asano Y, Akamata K, Takahashi T, Noda S, Taniguchi T, Toyama T, Aozasa N, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T (2014) Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis. Arch Dermatol Res 306:4","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"13_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/annrheumdis-2014-205326","volume":"75","author":"Naoki Iwamoto","year":"2014","unstructured":"Iwamoto N, Vettori S, Maurer B, Brock M, Pachera E, Jungel A, Calcagni M, Gay RE, Whitfield ML, Distler JH, Gay S, Distler O (2016) Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression. Ann Rheum Dis 75:1","journal-title":"Annals of the Rheumatic Diseases"},{"key":"13_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2012.01.005","volume":"143","author":"H Jiang","year":"2012","unstructured":"Jiang H, Xiao R, Lian X, Kanekura T, Luo Y, Yin Y, Zhang G, Yang Y, Wang Y, Zhao M, Lu Q (2012) Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+\u2009T cells from patients with systemic sclerosis. Clin Immunol 143:1","journal-title":"Clin Immunol"},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ajpath.2011.10.030","volume":"180","author":"I Kajihara","year":"2012","unstructured":"Kajihara I, Jinnin M, Yamane K, Makino T, Honda N, Igata T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts. Am J Pathol 180:2","journal-title":"Am J Pathol"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14397595.2014.899736","volume":"25","author":"H Kataoka","year":"2015","unstructured":"Kataoka H, Yasuda S, Fukaya S, Oku K, Horita T, Atsumi T, Koike T (2015) Decreased expression of Runx1 and lowered proportion of Foxp3(+) CD25(+) CD4(+) regulatory T cells in systemic sclerosis. Mod Rheumatol 25:1","journal-title":"Mod Rheumatol"},{"key":"13_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/exd.12173","volume":"22","author":"S Koba","year":"2013","unstructured":"Koba S, Jinnin M, Inoue K, Nakayama W, Honda N, Makino K, Kajihara I, Makino T, Fukushima S, Ihn H (2013) Expression analysis of multiple microRNAs in each patient with scleroderma. Exp Dermatol 22:7","journal-title":"Exp Dermatol"},{"key":"13_CR37","unstructured":"Kowal-Bielecka O (2010) An update on systemic sclerosis. Ann Acad Med Stetin 56(Suppl 1):80\u201382"},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/annrheumdis-2012-201615","volume":"72","author":"M Kramer","year":"2013","unstructured":"Kramer M, Dees C, Huang J, Schlottmann I, Palumbo-Zerr K, Zerr P, Gelse K, Beyer C, Distler A, Marquez VE, Distler O, Schett G, Distler JH (2013) Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis. Ann Rheum Dis 72:4","journal-title":"Ann Rheum Dis"},{"key":"13_CR39","first-page":"5","volume":"40","author":"CF Kuo","year":"2011","unstructured":"Kuo CF, See LC, Yu KH, Chou IJ, Tseng WY, Chang HC, Shen YM, Luo SF (2011) Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 40:5","journal-title":"Scand J Rheumatol"},{"key":"13_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/08916930802406300","volume":"42","author":"Y Kuwatsuka","year":"2009","unstructured":"Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S (2009) Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis. Autoimmunity 42:2","journal-title":"Autoimmunity"},{"key":"13_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/03009740902758875","volume":"38","author":"W Lei","year":"2009","unstructured":"Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q (2009) Abnormal DNA methylation in CD4+\u2009T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 38:5","journal-title":"Scand J Rheumatol"},{"key":"13_CR42","first-page":"2","volume":"32","author":"H Li","year":"2012","unstructured":"Li H, Yang R, Fan X, Gu T, Zhao Z, Chang D, Wang W (2012) MicroRNA array analysis of microRNAs related to systemic scleroderma. Rheumatol Int 32:2","journal-title":"Rheumatol Int"},{"key":"13_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.34376","volume":"64","author":"X Lian","year":"2012","unstructured":"Lian X, Xiao R, Hu X, Kanekura T, Jiang H, Li Y, Wang Y, Yang Y, Zhao M, Lu Q (2012) DNA demethylation of CD40l in CD4+\u2009T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum 64:7","journal-title":"Arthritis Rheum"},{"key":"13_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","volume":"41","author":"Qianjin Lu","year":"2013","unstructured":"Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41:1\u20135","journal-title":"Journal of Autoimmunity"},{"key":"13_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","volume":"41","author":"Yangyang Luo","year":"2013","unstructured":"Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161\u2013167","journal-title":"Journal of Autoimmunity"},{"key":"13_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biocel.2015.05.023","volume":"67","author":"Yangyang Luo","year":"2015","unstructured":"Luo Y, Wang Y, Shu Y, Lu Q, Xiao R (2015) Epigenetic mechanisms: an emerging role in pathogenesis and its therapeutic potential in systemic sclerosis. Int J Biochem Cell Biol 67:92\u2013100","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"13_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2230.2011.04158.x","volume":"37","author":"K Makino","year":"2012","unstructured":"Makino K, Jinnin M, Kajihara I, Honda N, Sakai K, Masuguchi S, Fukushima S, Inoue Y, Ihn H (2012) Circulating miR-142-3p levels in patients with systemic sclerosis. Clin Exp Dermatol 37:1","journal-title":"Clin Exp Dermatol"},{"key":"13_CR48","first-page":"1","volume":"133","author":"K Makino","year":"2013","unstructured":"Makino K, Jinnin M, Aoi J, Hirano A, Kajihara I, Makino T, Sakai K, Fukushima S, Inoue Y, Ihn H (2013a) Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts. J Investig Dermatology 133:1","journal-title":"J Investig Dermatology"},{"key":"13_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4049\/jimmunol.1200822","volume":"190","author":"K Makino","year":"2013","unstructured":"Makino K, Jinnin M, Hirano A, Yamane K, Eto M, Kusano T, Honda N, Kajihara I, Makino T, Sakai K, Masuguchi S, Fukushima S, Ihn H (2013b) The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. J Immunol 190:8","journal-title":"J Immunol"},{"key":"13_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/BOR.0000000000000324","volume":"28","author":"M Manetti","year":"2016","unstructured":"Manetti M (2016) Emerging biomarkers in systemic sclerosis. Curr Opin Rheumatol 28:6","journal-title":"Curr Opin Rheumatol"},{"key":"13_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37712","volume":"65","author":"M Manetti","year":"2013","unstructured":"Manetti M, Guiducci S, Romano E, Rosa I, Ceccarelli C, Mello T, Milia AF, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M (2013) Differential expression of junctional adhesion molecules in different stages of systemic sclerosis. Arthritis Rheumatol 65:1","journal-title":"Arthritis Rheumatol"},{"key":"13_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCRESAHA.107.171025","volume":"102","author":"CC Matouk","year":"2008","unstructured":"Matouk CC, Marsden PA (2008) Epigenetic regulation of vascular endothelial gene expression. Circ Res 102:8","journal-title":"Circ Res"},{"key":"13_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/art.27443","volume":"62","author":"B Maurer","year":"2010","unstructured":"Maurer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O (2010) MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62:6","journal-title":"Arthritis Rheum"},{"key":"13_CR54","doi-asserted-by":"crossref","unstructured":"Muangchan C, Baron M, Pope J (2013) The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review. J Rheumatol 40:9","DOI":"10.3899\/jrheum.121380"},{"issue":"11","key":"13_CR55","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/rheumatology\/keu285","volume":"54","author":"Vivek Nagaraja","year":"2014","unstructured":"Nagaraja V, Denton CP, Khanna D (2015) Old medications and new targeted therapies in systemic sclerosis. Rheumatology (Oxford) 54:11","journal-title":"Rheumatology"},{"key":"13_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4049\/jimmunol.1100591","volume":"188","author":"T Nakashima","year":"2012","unstructured":"Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 188:8","journal-title":"J Immunol"},{"key":"13_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.berh.2010.10.007","volume":"24","author":"M Nikpour","year":"2010","unstructured":"Nikpour M, Stevens WM, Herrick AL, Proudman SM (2010) Epidemiology of systemic sclerosis. Best Pract Res Clin Rheumatol 24:6","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"13_CR58","doi-asserted-by":"crossref","unstructured":"Noda S, Asano Y, Nishimura S, Taniguchi T, Fujiu K, Manabe I, Nakamura K, Yamashita T, Saigusa R, Akamata K, Takahashi T, Ichimura Y, Toyama T, Tsuruta D, Trojanowska M, Nagai R, Sato S (2014) Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nature Commun 5:5797","DOI":"10.1038\/ncomms6797"},{"key":"13_CR59","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly S, Ciechomska M, Fullard N, Przyborski S, van Laar JM (2016) IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics. Sci Rep 6:25066","DOI":"10.1038\/srep25066"},{"key":"13_CR60","unstructured":"Pattanaik D, Brown M, Postlethwaite AE (2011) Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res 4:105\u2013125"},{"key":"13_CR61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/1756-185X.13175","volume":"20","author":"R Rezaei","year":"2017","unstructured":"Rezaei R, Mahmoudi M, Gharibdoost F, Kavosi H, Dashti N, Imeni V, Jamshidi A, Aslani S, Mostafaei S, Vodjgani M (2017) IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis. Int J Rheum Dis 20:10","journal-title":"Int J Rheum Dis"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/annrheumdis-2015-207483","volume":"75","author":"E Romano","year":"2016","unstructured":"Romano E, Chora I, Manetti M, Mazzotta C, Rosa I, Bellando-Randone S, Blagojevic J, Soares R, Avouac J, Allanore Y, Ibba-Manneschi L, Matucci-Cerinic M, Guiducci S (2016) Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis. Ann Rheumatol Dis 75:8","journal-title":"Ann Rheumatol Dis"},{"key":"13_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1358836X0000500304","volume":"5","author":"LI Romero","year":"2000","unstructured":"Romero LI, Zhang DN, Cooke JP, Ho HK, Avalos E, Herrera R, Herron GS (2000) Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma. Vasc Med 5:3","journal-title":"Vasc Med"},{"key":"13_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jid.2017.04.035","volume":"137","author":"R Saigusa","year":"2017","unstructured":"Saigusa R, Asano Y, Nakamura K, Hirabayashi M, Miura S, Yamashita T, Taniguchi T, Ichimura Y, Takahashi T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S (2017) Systemic sclerosis dermal fibroblasts suppress Th1 cytokine production via galectin-9 overproduction due to fli1 deficiency. J Invest Dermat 137:9","journal-title":"J Invest Dermat"},{"issue":"2","key":"13_CR65","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","volume":"81","author":"LILIAN SCUSSEL-LONZETTI","year":"2002","unstructured":"Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, Raymond Y, Senecal JL (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81:2","journal-title":"Medicine"},{"issue":"1","key":"13_CR66","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/art.37705","volume":"65","author":"Simona Serrat\u00ec","year":"2012","unstructured":"Serrati S, Chilla A, Laurenzana A, Margheri F, Giannoni E, Magnelli L, Chiarugi P, Dotor J, Feijoo E, Bazzichi L, Bombardieri S, Kahaleh B, Fibbi G, Del Rosso M (2013) Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)\/transforming growth factor beta-dependent mesenchymal-to-mesenchymal transition. Arthritis Rheum 65:1","journal-title":"Arthritis & Rheumatism"},{"key":"13_CR67","doi-asserted-by":"crossref","unstructured":"Shi J, Chi S, Xue J, Yang J, Li F, Liu X (2016) Emerging role and therapeutic implication of wnt signaling pathways in autoimmune diseases. J Immunol Res 2016:9392132","DOI":"10.1155\/2016\/9392132"},{"key":"13_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3899\/jrheum.140502","volume":"42","author":"SO Steen","year":"2015","unstructured":"Steen SO, Iversen LV, Carlsen AL, Burton M, Nielsen CT, Jacobsen S, Heegaard NH (2015) The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus. J Rheumatol 42:2","journal-title":"J Rheumatol"},{"key":"13_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/ard.2002.004838","volume":"63","author":"GH Stummvoll","year":"2004","unstructured":"Stummvoll GH, Aringer M, Grisar J, Steiner CW, Smolen JS, Knobler R, Graninger WB (2004) Increased transendothelial migration of scleroderma lymphocytes. Ann Rheum Dis 63:5","journal-title":"Ann Rheum Dis"},{"key":"13_CR70","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1126\/scisignal.2004592","volume":"7","author":"S Svegliati","year":"2014","unstructured":"Svegliati S, Marrone G, Pezone A, Spadoni T, Grieco A, Moroncini G, Grieco D, Vinciguerra M, Agnese S, Jungel A, Distler O, Musti AM, Gabrielli A, Avvedimento EV (2014) Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis. Sci Signal 7:341","journal-title":"Sci Signal"},{"issue":"11","key":"13_CR71","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/rheumatology\/ket254","volume":"52","author":"Shigeru Tanaka","year":"2013","unstructured":"Tanaka S, Suto A, Ikeda K, Sanayama Y, Nakagomi D, Iwamoto T, Suzuki K, Kambe N, Matsue H, Matsumura R, Kashiwakuma D, Iwamoto I, Nakajima H (2013) Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor beta. Rheumatology (Oxford) 52:11","journal-title":"Rheumatology"},{"key":"13_CR72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3899\/jrheum.161092","volume":"44","author":"T Taniguchi","year":"2017","unstructured":"Taniguchi T, Asano Y, Nakamura K, Yamashita T, Saigusa R, Ichimura Y, Takahashi T, Toyama T, Yoshizaki A, Sato S (2017) Fli1 deficiency induces CXCL6 expression in dermal fibroblasts and endothelial cells, contributing to the development of fibrosis and vasculopathy in systemic sclerosis. J Rheumatol 44:8","journal-title":"J Rheumatol"},{"key":"13_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4933-11-1","volume":"11","author":"L Tserel","year":"2014","unstructured":"Tserel L, Limbach M, Saare M, Kisand K, Metspalu A, Milani L, Peterson P (2014) CpG sites associated with NRP1, NRXN2 and miR-29b-2 are hypomethylated in monocytes during ageing. Immun Ageing 11:1","journal-title":"Immun Ageing"},{"key":"13_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/art.39828","volume":"68","author":"PS Tsou","year":"2016","unstructured":"Tsou PS, Wren JD, Amin MA, Schiopu E, Fox DA, Khanna D, Sawalha AH (2016) Histone deacetylase 5 is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors. Arthritis Rheumatol 68:12","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"13_CR75","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1073\/pnas.1813006116","volume":"116","author":"Pei-Suen Tsou","year":"2019","unstructured":"Tsou PS, Campbell P, Amin MA, Coit P, Miller S, Fox DA, Khanna D, Sawalha AH (2019) Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma. Proc Natl Acad Sci USA 116:9","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"13_CR76","first-page":"10","volume":"16","author":"Z Vadasz","year":"2014","unstructured":"Vadasz Z, Rimar D (2014) New potential biomarkers for disease activity and fibrosis in systemic sclerosis. Israel Med Assoc J 16:10","journal-title":"Israel Med Assoc J"},{"key":"13_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/annrheumdis-2017-212911","volume":"78","author":"M van der Kroef","year":"2019","unstructured":"van der Kroef M, Castellucci M, Mokry M, Cossu M, Garonzi M, Bossini-Castillo LM, Chouri E, Wichers CGK, Beretta L, Trombetta E, Silva-Cardoso S, Vazirpanah N, Carvalheiro T, Angiolilli C, Bekker CPJ, Affandi AJ, Reedquist KA, Bonte-Mineur F, Zirkzee EJM, Bazzoni F, Radstake TRDJ, Rossato M (2019) Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting. Ann Rheum Dis 78:4","journal-title":"Ann Rheum Dis"},{"key":"13_CR78","doi-asserted-by":"crossref","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger Jr TA, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Muller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) Classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheumatol 65:11","DOI":"10.1002\/art.38098"},{"key":"13_CR79","first-page":"10","volume":"17","author":"Y Wang","year":"2013","unstructured":"Wang Y, Kahaleh B (2013) Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma. J Cell Mol Med 17:10","journal-title":"J Cell Mol Med"},{"key":"13_CR80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.21948","volume":"54","author":"Y Wang","year":"2006","unstructured":"Wang Y, Fan PS, Kahaleh B (2006) Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheumatol 54:7","journal-title":"Arthritis Rheumatol"},{"key":"13_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2013.06.006","volume":"149","author":"Y Wang","year":"2013","unstructured":"Wang Y, Yang Y, Luo Y, Yin Y, Wang Q, Li Y, Kanekura T, Wang J, Liang G, Zhao M, Lu Q, Xiao R (2013a) Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis. Clin Immunol 149:1","journal-title":"Clin Immunol"},{"key":"13_CR82","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2013.06.018","volume":"72","author":"Z Wang","year":"2013","unstructured":"Wang Z, Jinnin M, Kudo H, Inoue K, Nakayama W, Honda N, Makino K, Kajihara I, Fukushima S, Inoue Y, Ihn H (2013b) Detection of hair-microRNAs as the novel potent biomarker: evaluation of the usefulness for the diagnosis of scleroderma. J Dermatol Sci 72:2","journal-title":"J Dermatol Sci"},{"key":"13_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gendis.2014.08.003","volume":"1","author":"RN Wang","year":"2014","unstructured":"Wang RN, Green J, Wang Z, Deng Y, Qiao M, Peabody M, Zhang Q, Ye J, Yan Z, Denduluri S, Idowu O, Li M, Shen C, Hu A, Haydon RC, Kang R, Mok J, Lee MJ, Luu HL, Shi LL (2014a) Bone morphogenetic protein (BMP) signaling in development and human diseases. Genes Dis 1:1","journal-title":"Genes Dis"},{"key":"13_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1868-7083-6-25","volume":"6","author":"Y Wang","year":"2014","unstructured":"Wang Y, Shu Y, Xiao Y, Wang Q, Kanekura T, Li Y, Wang J, Zhao M, Lu Q, Xiao R (2014b) Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis. Clin Epigenetics 6:1","journal-title":"Clin Epigenetics"},{"key":"13_CR85","first-page":"1","volume":"171","author":"YY Wang","year":"2014","unstructured":"Wang YY, Wang Q, Sun XH, Liu RZ, Shu Y, Kanekura T, Huang JH, Li YP, Wang JC, Zhao M, Lu QJ, Xiao R (2014c) DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+\u2009T cells of patients with systemic sclerosis. Br J Dermatol 171:1","journal-title":"Br J Dermatol"},{"key":"13_CR86","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clim.2015.03.006","volume":"161","author":"Q Wang","year":"2015","unstructured":"Wang Q, Xiao Y, Shi Y, Luo Y, Li Y, Zhao M, Lu Q, Xiao R (2015) Overexpression of JMJD3 may contribute to demethylation of H3K27me3 in CD4+\u2009T cells from patients with systemic sclerosis. Clin Immunol 161:2","journal-title":"Clin Immunol"},{"issue":"21","key":"13_CR87","doi-asserted-by":"publisher","first-page":"12319","DOI":"10.1073\/pnas.1635114100","volume":"100","author":"M. L. Whitfield","year":"2003","unstructured":"Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamenschikov A, McCalmont TH, Brown PO, Botstein D, Connolly MK (2003) Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci USA 100:21","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"13_CR88","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/keh671","volume":"44","author":"F. A. Wollheim","year":"2005","unstructured":"Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 44:10","journal-title":"Rheumatology"},{"key":"13_CR89","doi-asserted-by":"crossref","unstructured":"Wu M, Assassi S (2013) The role of type 1 interferon in systemic sclerosis. Front Immunol 4:266","DOI":"10.3389\/fimmu.2013.00266"},{"key":"13_CR90","first-page":"11","volume":"11","author":"D Xu","year":"2016","unstructured":"Xu D, Hou Y, Zheng Y, Zheng Y, Li M, Zeng X (2016) The 2013 American College of Rheumatology\/European league against rheumatism classification criteria for systemic sclerosis could classify systemic sclerosis patients at earlier stage: data from a Chinese EUSTAR Center. PLoS One 11:11","journal-title":"PLoS One"},{"key":"13_CR91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/cr.2011.42","volume":"21","author":"M Yun","year":"2011","unstructured":"Yun M, Wu J, Workman JL, Li B (2011) Readers of histone modifications. Cell Res 21:4","journal-title":"Cell Res"},{"issue":"1","key":"13_CR92","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/annrheumdis-2014-205740","volume":"75","author":"Pawel Zerr","year":"2014","unstructured":"Zerr P, Palumbo-Zerr K, Huang J, Tomcik M, Sumova B, Distler O, Schett G, Distler JH (2016) Sirt1 regulates canonical TGF-\u03b2 signalling to control fibroblast activation and tissue fibrosis. Ann Rheum Dis 75:1","journal-title":"Annals of the Rheumatic Diseases"},{"key":"13_CR93","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.biopha.2016.12.080","volume":"87","author":"Bin Zhou","year":"2017","unstructured":"Zhou B, Zhu H, Luo H, Gao S, Dai X, Li Y, Zuo X (2017) MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1. Biomed Pharmacother 87:412\u2013418","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"13_CR94","first-page":"3","volume":"32","author":"H Zhu","year":"2012","unstructured":"Zhu H, Li Y, Qu S, Luo H, Zhou Y, Wang Y, Zhao H, You Y, Xiao X, Zuo X (2012) MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol 32:3","journal-title":"J Clin Immunol"},{"key":"13_CR95","first-page":"6","volume":"33","author":"H Zhu","year":"2013","unstructured":"Zhu H, Luo H, Li Y, Zhou Y, Jiang Y, Chai J, Xiao X, You Y, Zuo X (2013) MicroRNA-21 in scleroderma fibrosis and its function in TGF-beta-regulated fibrosis-related genes expression. J Clin Immunol 33:6","journal-title":"J Clin Immunol"},{"key":"13_CR96","doi-asserted-by":"crossref","unstructured":"Zhu H, Zhu C, Mi W, Chen T, Zhao H, Zuo X, Luo H, Li QZ (2018) Integration of genome-wide DNA methylation and transcription uncovered aberrant methylation-regulated genes and pathways in the peripheral blood mononuclear cells of systemic sclerosis. Int J Rheumatol 2018:7342472","DOI":"10.1155\/2018\/7342472"}],"container-title":["Advances in Experimental Medicine and Biology","Epigenetics in Allergy and Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-3449-2_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T06:46:26Z","timestamp":1722926786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-15-3449-2_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9789811534485","9789811534492"],"references-count":96,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-3449-2_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"23 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}